Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan 27;8(1):4.
doi: 10.1186/s40413-015-0055-2. eCollection 2015.

World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics

Alessandro Fiocchi #  1 , Ruby Pawankar #  2 , Carlos Cuello-Garcia  3   4 , Kangmo Ahn  5 , Suleiman Al-Hammadi  6 , Arnav Agarwal  3   7 , Kirsten Beyer  8 , Wesley Burks  9 , Giorgio W Canonica  10 , Motohiro Ebisawa  11 , Shreyas Gandhi  3   7 , Rose Kamenwa  12 , Bee Wah Lee  13 , Haiqi Li  14 , Susan Prescott  15 , John J Riva  16 , Lanny Rosenwasser  17 , Hugh Sampson  18 , Michael Spigler  19 , Luigi Terracciano  20 , Andrea Vereda-Ortiz  21 , Susan Waserman  22 , Juan José Yepes-Nuñez  3 , Jan L Brożek  3   22 , Holger J Schünemann  3   22
Affiliations

World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics

Alessandro Fiocchi et al. World Allergy Organ J. .

Abstract

Background: Prevalence of allergic diseases in infants, whose parents and siblings do not have allergy, is approximately 10% and reaches 20-30% in those with an allergic first-degree relative. Intestinal microbiota may modulate immunologic and inflammatory systemic responses and, thus, influence development of sensitization and allergy. Probiotics have been reported to modulate immune responses and their supplementation has been proposed as a preventive intervention.

Objective: The World Allergy Organization (WAO) convened a guideline panel to develop evidence-based recommendations about the use of probiotics in the prevention of allergy.

Methods: We identified the most relevant clinical questions and performed a systematic review of randomized controlled trials of probiotics for the prevention of allergy. We followed the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to develop recommendations. We searched for and reviewed the evidence about health effects, patient values and preferences, and resource use (up to November 2014). We followed the GRADE evidence-to-decision framework to develop recommendations.

Results: Currently available evidence does not indicate that probiotic supplementation reduces the risk of developing allergy in children. However, considering all critical outcomes in this context, the WAO guideline panel determined that there is a likely net benefit from using probiotics resulting primarily from prevention of eczema. The WAO guideline panel suggests: a) using probiotics in pregnant women at high risk for having an allergic child; b) using probiotics in women who breastfeed infants at high risk of developing allergy; and c) using probiotics in infants at high risk of developing allergy. All recommendations are conditional and supported by very low quality evidence.

Conclusions: WAO recommendations about probiotic supplementation for prevention of allergy are intended to support parents, clinicians and other health care professionals in their decisions whether to use probiotics in pregnancy and during breastfeeding, and whether to give them to infants.

Keywords: Allergy; GRADE; Practice guidelines; Prevention; Probiotics.

PubMed Disclaimer

References

    1. Haahtela T, von Hertzen L, Makela M, Hannuksela M. Allergy Programme Working G: Finnish Allergy Programme 2008–2018–time to act and change the course. Allergy. 2008;63:634–45. doi: 10.1111/j.1398-9995.2008.01712.x. - DOI - PubMed
    1. Prescott SL, Dunstan JA, Hale J, Breckler L, Lehmann H, Weston S, Richmond P. Clinical effects of probiotics are associated with increased interferon-gamma responses in very young children with atopic dermatitis. Clin Exp Allergy. 2005;35:1557–64. doi: 10.1111/j.1365-2222.2005.02376.x. - DOI - PubMed
    1. Arshad SH, Kurukulaaratchy RJ, Fenn M, Matthews S. Early life risk factors for current wheeze, asthma, and bronchial hyperresponsiveness at 10 years of age. Chest. 2005;127:502–8. doi: 10.1378/chest.127.2.502. - DOI - PubMed
    1. Agostoni C, Axelsson I, Goulet O, Koletzko B, Michaelsen KF, Puntis JW, Rigo J, Shamir R, Szajewska H, Turck D. Prebiotic oligosaccharides in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2004;39:465–73. doi: 10.1097/00005176-200411000-00003. - DOI - PubMed
    1. Shreiner A, Huffnagle GB, Noverr MC. The "Microflora Hypothesis" of allergic disease. Adv Exp Med Biol. 2008;635:113–34. doi: 10.1007/978-0-387-09550-9_10. - DOI - PubMed